Skip to Main Content

Author Details

Hsian-Rong Tseng
Jonsson Comprehensive Cancer Center, University of California los angeles
2002
147
55
PMIDPaper TitleJournal TitlePublished Year
36056798Reply.Hepatology2023
38037608Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma.Nano Today2023
37017310Retraction of "Precision-Guided Nanospears for Targeted and High-Throughput Intracellular Gene Delivery".ACS Nano2023
37333287High-throughput mRNA-seq atlas of human placenta shows vast transcriptome remodeling from first to third trimester.bioRxiv2023
36960953Nano-On-Nano: Responsive Nanosubstrate-Mediated Liposome Delivery with High Cellular Uptake Efficiency.ACS Appl Bio Mater2023
36711067Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs.Nano Today2023
35908246HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.Hepatology2023
34664394Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.Liver Transpl2022
35543075Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma.J Gastroenterol Hepatol2022
35486030Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations.Adv Sci (Weinh)2022
36175411Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.Nat Commun2022
36161213Hepatocellular carcinoma surveillance: current practice and future directions.Hepatoma Res2022
35124841Early detection of primary liver cancer using plasma cell-free DNA fragmentomics: Do all the pieces come together?Hepatology2022
35040930Sex differences in microRNA expression in first and third trimester human placentaâ¿ .Biol Reprod2022
34896918Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.Biosens Bioelectron2022
32017145Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.Hepatology2021
33728665State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.Hepatology2021
34386205Diagnostic Criteria and LI-RADS for Hepatocellular Carcinoma.Clin Liver Dis (Hoboken)2021
34105245Supramolecular Nanosubstrate-Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion.Small2021
34344888Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders.Nat Commun2021
34212072Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.Adv Mater Technol2021
34010422The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States.J Natl Cancer Inst2021
34203086The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.Cancers (Basel)2021
34030457High-throughput miRNA sequencing of the human placenta: expression throughout gestation.Epigenomics2021
31566837Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications.Adv Mater2020
34220409Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies.Adv Funct Mater2020
32017048Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.Clin Pharmacol Ther2020
33024921Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.Hepatol Commun2020
33097539Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies.Sci Adv2020
32637655Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.NPJ Precis Oncol2020
32772088Sexually Dimorphic Crosstalk at the Maternal-Fetal Interface.J Clin Endocrinol Metab2020
32618993A ratiometric photoacoustic imaging approach for semi-quantitative determination of aggregation efficiency in vivo.Nanoscale2020
32895384Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.Nat Commun2020
32525199A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer.J Mater Chem B2020
32440478Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9-Mediated Knockin of Retinoschisin 1 Gene-A Potential Nonviral Therapeutic Solution for X-Linked Juvenile Retinoschisis.Adv Sci (Weinh)2020
30892008Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.ACS Appl Mater Interfaces2019
31244925A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Theranostics2019
31565541Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells.Curr Obstet Gynecol Rep2019
31392269Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells.Sci Adv2019
28892262Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection.Adv Healthc Mater2018
30154147Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential.Cancer Res2018
29851454Cross-Linked Fluorescent Supramolecular Nanoparticles for Intradermal Controlled Release of Antifungal Drug-A Therapeutic Approach for Onychomycosis.ACS Nano2018
29551650NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.Adv Drug Deliv Rev2018
29666832Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer.Am J Clin Exp Urol2018
29470068Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.J Med Chem2018
29442211Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.Ann Surg Oncol2018
29631554CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.BMC Cancer2018
29624843A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.Liver Transpl2018
29536729Precision-Guided Nanospears for Targeted and High-Throughput Intracellular Gene Delivery.ACS Nano2018
27997116Cross-Linked Fluorescent Supramolecular Nanoparticles as Finite Tattoo Pigments with Controllable Intradermal Retention Times.ACS Nano2017
  • 1 - 50 of 147

Recommended Authors

Youjin V Lee
University of Chicago
Career Start Year 2015
Number of shared co-authors 0
Hao Li
Shaanxi University of Science and Technology
Career Start Year 2013
Number of shared co-authors 0
Thomas C Ferrante
Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year 2012
Number of shared co-authors 0
John W Hickey
Stanford University School of Medicine, Stanford University
Career Start Year 2011
Number of shared co-authors 0
Hadi Shafiee
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
Young-Won Kim
Baylor College of Medicine
Career Start Year 2009
Number of shared co-authors 0
Weihua Guan
Pennsylvania State University, University Park
Career Start Year 2007
Number of shared co-authors 2
Helene Andersson-Svahn
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 0
Xiao-Peng He
Ottawa Hospital Research Institute
Career Start Year 2006
Number of shared co-authors 0
Euisik Yoon
University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 0
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Career Start Year 2004
Number of shared co-authors 0
Jianping Fu
College of life sciences, Jiangxi Normal university
Career Start Year 2004
Number of shared co-authors 1
Christopher J Easley
Auburn University
Career Start Year 2003
Number of shared co-authors 0
Michaela Bowden
Dana-Farber Cancer Institute
Career Start Year 2002
Number of shared co-authors 4
Deng Pan
College of Plant Protection, Southwest University
Career Start Year 2001
Number of shared co-authors 0
Zhenjia Wang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2000
Number of shared co-authors 0
Yamuna Krishnan
The University of Chicago
Career Start Year 2000
Number of shared co-authors 1
Sabine Schmidt
German Cancer Research Center (DKFZ)
Career Start Year 1999
Number of shared co-authors 0
Fuan Wang
Zhongnan Hospital of Wuhan University
Career Start Year 1999
Number of shared co-authors 0
Soo Young Park
Kyungpook National University
Career Start Year 1999
Number of shared co-authors 0
Ji-Hoon Lee
Jeonbuk National University
Career Start Year 1997
Number of shared co-authors 0
Anup K Singh
Joint BioEnergy Institute, USA Lawrence Livermore National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Sangeeta N Bhatia
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 1
Jackie Y Ying
Institute of Materials Research and Engineering
Career Start Year 1993
Number of shared co-authors 1
Peter C Searson
Institute for NanoBioTechnology, Johns Hopkins University
Career Start Year 1992
Number of shared co-authors 0
Mei He
Sichuan University
Career Start Year 1992
Number of shared co-authors 0
Ashutosh Chilkoti
Duke University
Career Start Year 1991
Number of shared co-authors 0
John P Nolan
Scintillon Institute
Career Start Year 1990
Number of shared co-authors 0
Larry A Nagahara
Johns Hopkins University
Career Start Year 1988
Number of shared co-authors 3
David R Walt
Brigham and Women's Hospital
Career Start Year 1987
Number of shared co-authors 0

Collaborators

Edwin M Posadas
Cedars-Sinai Medical Center
Co-authored papers 23
Vatche G Agopian
David Geffen School of Medicine , University of California los angeles
Co-authored papers 22
Jie-Fu Chen
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Matthew J Smalley
European Cancer Stem Cell Research Institute, Cardiff University
Co-authored papers 11
Sungyong You
Cedars-Sinai Medical Center
Co-authored papers 11
James R Heath
Institute of Systems Biology, University of Washington
Co-authored papers 10
Yu Jen Jan
Cedars-Sinai Medical Center
Co-authored papers 10
Steven-Huy B Han
David Geffen School of Medicine , University of California los angeles
Co-authored papers 5
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Co-authored papers 5
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Li-Ching Chen
College of Life Science, China Medical University Taichung 406040
Co-authored papers 4
Owen N Witte
University of California los angeles
Co-authored papers 4
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 3
Dolores Di Vizio
Cedars-Sinai Medical Center
Co-authored papers 3
Xianghong Jasmine Zhou
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 3
Peter Kuhn
University of Tubingen
Co-authored papers 2
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Co-authored papers 2
Ryan Dittamore
Decipher Biosciences Inc.
Co-authored papers 2
Allison Welsh
Exact Sciences Corporation
Co-authored papers 2
Arne Gruen
Charite-University Hospital Berlin
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Venkataraman R Muthusamy
Co-authored papers 2
Robert L Grossman
University of Chicago
Co-authored papers 2
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers 2
Phillip G Febbo
Illumina Inc.
Co-authored papers 2
Jake Vinson
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 2
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Subbian Ananth Karumanchi
Co-authored papers 2
Beatrice S Knudsen
University of Utah
Co-authored papers 2
Release 1.2